Health
Cats point the way to potential COVID-19 remedies – FierceBiotech
University of Alberta scientists reported that a drug being developed by Anivive Lifesciences to treat feline infectious peritonitis prevented human coronaviruses from replicating in cell studies. They believe the drug should be rushed into human trials to tr…
Last week, Gilead Sciences said it would test its COVID-19 drug remdesivir against a related compound in its library called GS-441524 in animal trials, after facing scrutiny over the latter drug, which has been used for years to treat feline infectious peritonitis (FIP) despite not being licensed for that use.
Now, another California biotech, Anivive Lifesciences, is working on a COVID-19 antiviral drug thats inspired by cats, and it has new preclinical research findings to back up the project….
-
General21 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth
-
General7 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business17 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks